ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK

Li, HaiShan; Deng, Wei; Qin, QiuLi; Lin, YueWei; Liu, Teng; Mo, GuoYe; Shao, Yang; Tang, YongChao; Yuan, Kai; Xu, LiangLiang*; Li, YongXian*; Zhang, ShunCong*广州中医药大学; 1
Biochemical Pharmacology2023-5DOI: 10.1016/j.bcp.2023.115502
5被引5阅读
引用收藏
分享

摘要

Osteoporosis, an immune disease characterized by bone mass loss and microstructure destruction, is often seen in postmenopausal women. Isoimperatorin (ISO), a bioactive, natural furanocoumarin isolated from many tradi-tional Chinese herbal medicines, has therapeutic effects against various diseases; however, its effect on bone homeostasis remains unclear. In this study, we investigated the effect of ISO on the differentiation and activation of osteoclast and its molecular mechanism in vitro, and evaluated the effect of ISO on bone metabolism by ovariectomized (OVX) rat model. In vitro experiments showed that ISO affected RANKL-induced MAPK, NFAT, NFATc1 trafficking and expression, osteoclast F-actin banding, osteoclast-characteristic gene expression, ROS inhibitory activity, and calcium oscillations, NF-kappa B signaling pathway. In vivo experiments showed that oral administration of ISO effectively reduced bone loss caused by ovariectomy and retained bone mass.Collectively, ISO inhibits RANK/RANKL binding, thereby reducing the activity of NFATc1, calcium, and ROS and inhibiting osteoclast generation. In addition, ISO protects bone mass by slowing osteoclast production and downregulating NFATc1 gene and protein expression in the bone tissue microenvironment and inhibits OVX-induced bone loss in vivo.

学科与关键词

关键词
IsoimperatorinRANKL-RANKMAPKROSOsteoclastSPR
相关
加载中…
  • A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species
    Wong, Puiian; Lv, Zheng; Li, Jinglan; Wei, Qiushi; Xu, LiangLiang*; Fang, Bin*; Luo, Yiwen*; He, Mincong*Oxidative Medicine and Cellular Longevity, 2022, 2022: 5982014.被引 6
  • A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
    Hong, Guoju; Chen, Zhenqiu; Han, Xiaorui; Zhou, Lin; Pang, Fengxiang; Wu, Rishana; Shen, Yingshan; He, Xiaoming; Hong, Zhinan; Li, Ziqi; He, Wei; Wei, Qiushi*Clinical and Translational Medicine, 2021, 11(5): e392.被引 31
  • Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway
    Qiu, Zuocheng; Li, Ling; Huang, Yuying; Shi, Keda; Zhang, Lizhong; Huang, Cuishan; Liang, Jiechao; Zeng, Qingqiang; Wang, Jiali; He, Xiangjiu; Qin, Ling; Wang, Xinluan*Journal of Orthopaedic Translation, 2022, 33: 55-69.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochemical Pharmacology
发表日期
2023-05
卷期
第 211 卷
页码
115502
DOI
10.1016/j.bcp.2023.115502
语言
ENGLISH
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province, China [2021A1515012168]; Administration of Traditional Chinese Medicine of Guangdong Province, China [20203004, 20221146]; Basic and Applied Basic Research Fund Project in Guangdong Province, China [2020A1515110948]; Application and foundation research project of Guangzhou, China [202201020500, 202201020295]

作者

  • L

    Li, HaiShan (第一作者)

    1 · guangzhou univ chinese med

  • D

    Deng, Wei

    1 · guangzhou univ chinese med

查看全部 12 位作者收起作者
  • Q

    Qin, QiuLi

    guangzhou univ chinese med · 1

  • L

    Lin, YueWei

    guangzhou univ chinese med · 1

  • L

    Liu, Teng

    1 · guangzhou univ chinese med

  • M

    Mo, GuoYe

    1 · guangzhou univ chinese med

  • S

    Shao, Yang

    guangzhou univ chinese med · 1

  • T

    Tang, YongChao

    1 · guangzhou univ chinese med

  • Y

    Yuan, Kai

    1 · guangzhou univ chinese med

  • X

    Xu, LiangLiang (通讯)

    1 · guangzhou univ chinese med

  • L

    Li, YongXian (通讯)

    1 · guangzhou univ chinese med

  • Z

    Zhang, ShunCong (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417